Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORWARD: BOTOX vs Topiramate for Chronic Migraine Prophylaxis
NCT02191579Phase 4Completed
- Sponsor
- Allergan
- Start
- Aug 2014
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in chronic migraine, sponsored by Allergan. Started Aug 2014; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT02191579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191579.